Preclinical data can be compelling, but the path from bench to bedside in ADC development is rarely straightforward. This panel discussion examines the factors that drive, and those that disrupt, successful translation across the full ADC development arc, from early discovery and preclinical modeling through IND-enabling studies to first-in-human trials and early clinical evaluation.
Panelists will draw on direct experience of ADC programs to explore where preclinical assumptions hold, where they break down, and how those lessons are informing more robust translational strategies.
Attend this webinar to:
Register now to join the discussion and stay tuned for panelist announcements!